Financials

  • Market Capitalization 1.9 B
  • Employee 87
  • Founded 2018
  • CEO N/A
  • Website www.tyra.bio
  • Headquarter Delaware, United States
  • FIGI BBG00RCQD9D1
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.08
ratio cours/chiffre d'affaires

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1991
SION
Sionna Therapeutics, Inc. - Common Stock
43.51 USD-1.00%-0.62%+19.07%+10.60%1.96 B USD
2000
VRDN
Viridian Therapeutics, Inc. - Common Stock
19.10 USD+0.58%-2.05%+15.20%-14.92%1.97 B USD
2012
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
17.64 USD+1.32%-2.00%+19.27%+109.75%1.96 B USD
2014
URGN
UroGen Pharma Ltd. - Ordinary Shares
39.55 USD+0.10%+6.00%+33.84%+108.16%1.93 B USD

Nouvelles